Small pharma IP licensing and acquisition support
A small, yet rapidly growing pharmaceutical startup developed an innovative technology in the smart pills sector and required review of most suitable strategies to monetize their new product through targeted collaboration strategy with pill manufacturers
SDI developed a bespoke intellectual property monetization framework and developed an action plan for several pill manufacturer types, as well as major monetization strategies (e.g. in-/out-licensing, joint ventures, etc.
SDI framework succeeded in streamlining client’s decision-making regarding IP monetization, enabling the creation of a scalable platform for seamless addition of new collaboration partners and rapid product launching